Clinical Market Research Reports

 A Study Trends and Market Outlook report aims at providing our readers with a high-level view of the clinical development space. The data for this market research report comes from over 140 Phase I decision-makers who were surveyed to share their insights into where the Phase I market is now and where it’s expected to head over the next four years. Check out the Report Preview.

This market research report is available for purchase below. Its goal is to provide readers with a high-level view of the clinical development space. For this report, 139 Phase II/III decision-makers were surveyed to share their insights into where the Phase II/III market is now and where it’s expected to head over the next four years.

This market research report is available for purchase below. Its goal is to provide readers with a high-level view of the clinical development space. For this report, 115 Late Phase decision-makers were surveyed to share their insights into where the Late Phase market is now and where it’s expected to head over the next four years.

The past three years have been quite eventful in the CRO world. We’ve had service provider mergers and mega-mergers. We’ve had biopharma mergers and mega-mergers. We’ve had IPOs and privatizations. The 2019 CRO Market Size report gives quantitative insight into the perpetual question: “What is the size of the CRO market?

Ask any HR manager working at a CRO or sponsor organization and they will tell you there is a war for talent when it comes to hiring and retaining high-quality CRAs. ISR decided to take a deep look at not only CRA salaries, but also signing bonuses, retention bonuses, raises, and turnover with the aim of benchmarking some industry trends. We collected data from 227 CRAs from various organizations and countries around the world.

This market research report is available for purchase below. It takes a look at user experiences with seven different clinical development outsourcing models.

This market research report is available for purchase below. Its goal is to provide detailed information to aid in making informed decisions when outsourcing Phase I work. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within a single site/office location, or an enterprise-wide license giving access to all employees within your organization.

This market research report is available for purchase below. It has been designed to give readers an educated approach to service provider selection and includes informed analysis of provider performance. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within a single site/office location, or an enterprise-wide license giving access to all employees within your organization.

This market research report is available for purchase below. Its goal is to provide detailed information to aid in making informed decisions when outsourcing Phase IV work. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within a single site/office location, or an enterprise-wide license giving access to all employees within your organization.

This market research report is available for purchase below. Its goal is to help both sponsors and providers stay current with market dynamics and anticipate changes that may be coming down the pike. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within a single site/office location, or an enterprise-wide license giving access to all employees within your organization.

This market research report is available for purchase below. For this study, Industry Standard Research (ISR) collected both qualitative and quantitative data. Qualitative telephone interviews were used to gain insight into mHealth expert viewpoints, while a quantitative, internet-based survey was used to collect hard data on familiarity with mHealth, anticipated implementation, and usage rates in recent or soon-to-be conducted clinical trials.

This market research report is available for purchase below. examines the industry perception of the eCOA/ePRO market based on the responses of 117 industry professionals experienced with these systems. ISR has asked respondents how their respective companies handle the decisions associated with outsourcing these systems as well as how they would prefer the outsourcing be handled.

This market research report is available for purchase below. It covers the state of the IRT and its apparent transition from standalone point products to more fully integrated systems that use and feed data into other eClinical systems such as EDC systems, CTMS, and eCOA systems, in addition to managing randomization and drug supply functions.

This market research report is available for purchase below. It examines the industry perception of the EDC market based on the responses of 148 industry professionals experienced with these systems. ISR has asked respondents how their respective companies handle the decisions associated with outsourcing these systems as well as how they would prefer the outsourcing be handled.

This market research report is available for purchase below. ISR surveyed 110 qualified CTMS decision-makers regarding their insights on topics such as CTMS selection drivers, outsourcing trends, use, and perceptions of providers. Respondents also shared general improvements they would like to see in the next generation of CTMS software and conveyed provider-specific advantages and improvement suggestions for their preferred system.

Technology forges a world where human connection is no longer inhibited by distance. Barriers are broken and replaced with virtual bridges that create unprecedented potential for an interconnected present and future. And no doubt the areas most affected by this technological nexus are ones dominated by human synergy. An area at the center of this change is the pharmaceutical industry, characterized by technological and medical advancement, but faithfully guided by the necessity to improve the human condition.

This market research report is available for purchase below. ISR conducted 11 in-depth interviews with tenured post-marketing safety and pharmacovigilance professionals from leading biotechnology and pharmaceutical companies in North America and Europe.

This market research report is available for purchase below. ISR conducted interviews with a cross-section of executive, director, and managerial level MM professionals from large, mid-size, and small pharmaceutical and biotech companies to gain a better understanding of managed markets departments, how they work, and the challenges they face.

This market research report is available for purchase below. It’s been designed to be used as a benchmarking tool for companies to compare their Medical Science Liaison functions to those of other pharmaceutical and biotech organizations. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within a single site/office location, or an enterprise-wide license giving access to all employees within your organization.